Related Experiment Video

Updated: Jul 2, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
10:52

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence

Published on: December 23, 2022

Patent ductus arteriosus: endovascular treatment in adult patient

Diego Felipe Gaia1, José Honório Palma, Hyung Chun Kim

  • 1Universidade Federal de São Paulo, São Paulo, SP - Brasil. drgaia@uol.com.br

Arquivos Brasileiros De Cardiologia
|August 19, 2008
PubMed

Insights

Patent ductus arteriosus (PDA) in adults is a high-risk condition. This report details an alternative, less invasive endovascular approach for PDA correction in adult patients.

Area of Science:

  • Cardiology
  • Congenital Heart Disease
  • Vascular Surgery

Background:

  • Patent ductus arteriosus (PDA) is a common congenital heart defect, typically corrected in infancy.
  • Untreated PDA in adults can cause serious complications like pulmonary hypertension and ventricular dysfunction.
  • Surgical correction in adults is often associated with high risks and controversy.

Observation:

  • This report focuses on an adult patient with PDA.
  • The patient underwent an alternative endovascular approach for PDA correction.
  • This method offers a potential alternative to traditional surgery.

Findings:

  • The endovascular approach was successfully employed in an adult PDA patient.
  • This minimally invasive technique provides a viable alternative for adult PDA management.
  • The procedure highlights advancements in treating adult congenital heart defects.

Implications:

  • This endovascular method may offer a safer, less invasive option for adult PDA patients.
  • It could reduce the risks associated with traditional surgical interventions.
  • Further research into endovascular techniques for adult congenital heart disease is warranted.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...